• Home
  • About CML
    • Who We Are
    • What we Do
    • Mission & Vision
    • The Patient Advisory Board
  • What is CML
  • Treatments
    • Access
    • Living Well
    • Clinical Trials
  • News
  • Contact
  • Home
  • About CML
    • Who We Are
    • What we Do
    • Mission & Vision
    • The Patient Advisory Board
  • What is CML
  • Treatments
    • Access
    • Living Well
    • Clinical Trials
  • News
  • Contact

CML & COVID-19 Important information

•22 October 2024

COVID vaccine information For CML patients living in Quebec, under the age of 60

Statement from the iCMLf for people with CML and COVID-19 Vaccines

Read the Expert Panel statement and important advice on CML & COVID-19

If you are a CML patient and you have tested positive for COVID-19, the iCMLf would like to hear from you.

To Visit the COVID-19 HUB of the International CML Foundation

Previous PostCML and COVID – 19 Case CollectionNext PostCanCertainty

Related Posts

ACCESS TO AFFORDABLE MEDICINE FOR ALL

CML Access to Medicine

APO-IMATINIB

Apo – imatinib – Treatment for CML



Society of Canada provides support, education and information on CML, current and emerging treatments and research initiatives for people living with CML and their families.

Contact Centre

1 (514) 239-5488

All Across Canada

Mon – Fri: 8.00am 6.00pm

Member Resources

  • About CML
  • What is CML
  • Contact Us
  • Treatments
  • News
  • Videos

Our Newsletter

Copyright ©2024 CML. All Rights Reserved. Legal and Privacy.